Tharimmune (THAR) presented new TH104 Phase 1 data at the American College of Gastroenterology 2024 Annual Scientific Meeting, underway in Philadelphia. The Phase 1 trial was a single-dose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback